Filing Details
- Accession Number:
- 0001209191-19-060018
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-11 16:10:12
- Reporting Period:
- 2019-12-09
- Accepted Time:
- 2019-12-11 16:10:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1654151 | Deciphera Pharmaceuticals Inc. | DCPH | Pharmaceutical Preparations (2834) | 200299725 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1713712 | Lee Daniel Flynn | C/O Deciphera Pharmaceuticals, Inc. 200 Smith Street Waltham MA 02451 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-09 | 30,175 | $1.89 | 54,675 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-09 | 30,175 | $55.00 | 24,500 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-12-10 | 28,822 | $1.89 | 53,322 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-10 | 28,822 | $55.00 | 24,500 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-12-10 | 93,930 | $1.89 | 118,430 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-10 | 93,930 | $55.00 | 24,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-12-09 | 30,175 | $0.00 | 30,175 | $1.89 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-12-10 | 28,822 | $0.00 | 28,822 | $1.89 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-12-10 | 93,930 | $0.00 | 93,930 | $1.89 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 136,649 | 2025-12-17 | No | 4 | M | Direct | |
| 107,827 | 2025-12-17 | No | 4 | M | Direct | |
| 13,897 | 2025-12-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 66,779 | Indirect | By Daniel L. Flynn Irrevocable Trust |
| Common Stock | 55,270 | Indirect | By Biochenomix, LLC |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable on the date of grant, December 18, 2015.
Billionaire Hedge Funds
